ConductScience.org, home

Paper25955428

A mathematical model to elucidate brain tumor abrogation by immunotherapy with T11 target structure.

Banerjee S and 2 others. PLoS One, 2015. Cited by 39 papers, by iCite.

Cite this record

ConductScience Library. A mathematical model to elucidate brain tumor abrogation by immunotherapy with T11 target structure. Papers, record 25955428. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25955428

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A mathematical model to elucidate brain tumor abrogation by immunotherapy with T11 target structure.
PubMed
Journal
PLoS One
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
39
iCite
Relative citation ratio, by iCite
1.29
iCite
Revised in PubMed
2018-11-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Banerjee SSandip
2Khajanchi SSubhas
3Chaudhuri SSwapna

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Brain NeoplasmsMajor topic
ImmunotherapyMajor topic
Membrane GlycoproteinsMajor topic
Models, BiologicalMajor topic
Animals
Animals, Newborn
CD8-Positive T-Lymphocytes
Female
Glioma
Humans
Interferon-gamma
Least-Squares Analysis
Macrophages
Male
Numerical Analysis, Computer-Assisted
Rats
Sheep
Transforming Growth Factor beta

Source PubMed

Download CSV of topics

References34

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110587310The detection of CD2+, CD4+, CD8+, and WC1+ T lymphocytes, B cells and macrophages in fixed and paraffin embedded bovine tissue using a range of antigen recovery and signal amplification techniques.Vet Immunol Immunopathol1999https://conductscience.org/library/papers/10587310PubMed
28953256Drug delivery to brain tumors.Bull Math Biol1996https://conductscience.org/library/papers/8953256PubMed
311895036The WHO classification of tumors of the nervous system.J Neuropathol Exp Neurol2002https://conductscience.org/library/papers/11895036PubMed
412716291
Preclinical Changes in Immunoreactivity and Cellular Architecture during the Progressive Development of Intracranial Neoplasms and an Immunotherapeutic Schedule with a Novel Biological Response Modifier, the T11TS / S-LFA3.
Asian Pac J Cancer Prev2002https://conductscience.org/library/papers/12716291PubMed
516227278How many human immunodeficiency virus type 1-infected target cells can a cytotoxic T-lymphocyte kill?J Virol2005https://conductscience.org/library/papers/16227278PubMed
610757345Immunosuppression mediated by tumor cells: a challenge for immunotherapeutic approaches.Hum Gene Ther2000https://conductscience.org/library/papers/10757345PubMed
719345698Distributed parameters deterministic model for treatment of brain tumors using Galerkin finite element method.Math Biosci2009https://conductscience.org/library/papers/19345698PubMed
819489983Virtual glioblastoma: growth, migration and treatment in a three-dimensional mathematical model.Cell Prolif2009https://conductscience.org/library/papers/19489983PubMed
922205943miR451 and AMPK mutual antagonism in glioma cell migration and proliferation: a mathematical model.PLoS One2011https://conductscience.org/library/papers/22205943PubMed
101312305Glioblastoma, transforming growth factor-beta, and Candida meningitis: a potential link.Am J Med1992https://conductscience.org/library/papers/1312305PubMed
1116237114Tumor progression can occur despite the induction of very high levels of self/tumor antigen-specific CD8+ T cells in patients with melanoma.J Immunol2005https://conductscience.org/library/papers/16237114PubMed
1216547267Contribution of CD8+ T cells to control of Mycobacterium tuberculosis infection.J Immunol2006https://conductscience.org/library/papers/16547267PubMed
138586458Histopathology, classification, and grading of gliomas.Glia1995https://conductscience.org/library/papers/8586458PubMed
1412675529Quantifying efficacy of chemotherapy of brain tumors with homogeneous and heterogeneous drug delivery.Acta Biotheor2002https://conductscience.org/library/papers/12675529PubMed
1510736214Simulated brain tumor growth dynamics using a three-dimensional cellular automaton.J Theor Biol2000https://conductscience.org/library/papers/10736214PubMed
1611596120Basic principles of immunological surveillance of the normal central nervous system.Glia2001https://conductscience.org/library/papers/11596120PubMed
1712242114Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review.Radiother Oncol2002https://conductscience.org/library/papers/12242114PubMed
1817823798Improving alloreactive CTL immunotherapy for malignant gliomas using a simulation model of their interactive dynamics.Cancer Immunol Immunother2008https://conductscience.org/library/papers/17823798PubMed
1914648016Interferon-gamma pharmacokinetics and pharmacodynamics in patients with colorectal cancer.Cancer Chemother Pharmacol2004https://conductscience.org/library/papers/14648016PubMed
2015758009Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.N Engl J Med2005https://conductscience.org/library/papers/15758009PubMed

See all 34 referencesDownload CSV of references

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.

PMIDTitleJournalYearIn PapersSource
41794979Fractional spatiotemporal Hahnfeldt tumor model with convergence analysis and optimal control.Sci Rep2026https://conductscience.org/library/papers/41794979PubMed
39155294Spatial computational modelling illuminates the role of the tumour microenvironment for treating glioblastoma with immunotherapies.NPJ Syst Biol Appl2024https://conductscience.org/library/papers/39155294PubMed
38099947Global stability and parameter analysis reinforce therapeutic targets of PD-L1-PD-1 and MDSCs for glioblastoma.J Math Biol2023https://conductscience.org/library/papers/38099947PubMed
36428963Distinct Dynamics of Migratory Response to PD-1 and CTLA-4 Blockade Reveals New Mechanistic Insights for Potential T-Cell Reinvigoration following Immune Checkpoint Blockade.Cells2022https://conductscience.org/library/papers/36428963PubMed
35814367KDELR1 Is an Independent Prognostic Predictor and Correlates With Immunity in Glioma.Front Oncol2022https://conductscience.org/library/papers/35814367PubMed
35482133Simulating the behaviour of glioblastoma multiforme based on patient MRI during treatments.J Math Biol2022https://conductscience.org/library/papers/35482133PubMed
35205057A Continuous Markov-Chain Model for the Simulation of COVID-19 Epidemic Dynamics.Biology (Basel)2022https://conductscience.org/library/papers/35205057PubMed
35125654Mathematical modeling and optimal intervention strategies of the COVID-19 outbreak.Nonlinear Dyn2022https://conductscience.org/library/papers/35125654PubMed
35070618Modeling the dynamics of COVID-19 pandemic with implementation of intervention strategies.Eur Phys J Plus2022https://conductscience.org/library/papers/35070618PubMed
34789751Spatiotemporal dynamics of a glioma immune interaction model.Sci Rep2021https://conductscience.org/library/papers/34789751PubMed
34771476An Agent-Based Model of Combination Oncolytic Viral Therapy and Anti-PD-1 Immunotherapy Reveals the Importance of Spatial Location When Treating Glioblastoma.Cancers (Basel)2021https://conductscience.org/library/papers/34771476PubMed
34631341Dynamics of coronavirus pandemic: effects of community awareness and global information campaigns.Eur Phys J Plus2021https://conductscience.org/library/papers/34631341PubMed
34423116An in silico glioblastoma microenvironment model dissects the immunological mechanisms of resistance to PD-1 checkpoint blockade immunotherapy.Small Methods2021https://conductscience.org/library/papers/34423116PubMed
33977079Mathematical modeling of the COVID-19 pandemic with intervention strategies.Results Phys2021https://conductscience.org/library/papers/33977079PubMed
33922302Personalized Immunotherapy Treatment Strategies for a Dynamical System of Chronic Myelogenous Leukemia.Cancers (Basel)2021https://conductscience.org/library/papers/33922302PubMed
33846838Multiscale modeling of glioma pseudopalisades: contributions from the tumor microenvironment.J Math Biol2021https://conductscience.org/library/papers/33846838PubMed
33679275Impact of social media advertisements on the transmission dynamics of COVID-19 pandemic in India.J Appl Math Comput2022https://conductscience.org/library/papers/33679275PubMed
32834653A mathematical model for COVID-19 transmission dynamics with a case study of India.Chaos Solitons Fractals2020https://conductscience.org/library/papers/32834653PubMed
32834603Modeling and forecasting the COVID-19 pandemic in India.Chaos Solitons Fractals2020https://conductscience.org/library/papers/32834603PubMed
32752627Forecasting the daily and cumulative number of cases for the COVID-19 pandemic in India.Chaos2020https://conductscience.org/library/papers/32752627PubMed

See all 29 cited byDownload CSV of cited by

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25955428

GET https://conductscience.org/api/papers/v1/25955428/references?page=2